CliffBio
small molecule

EXTENDED PHENYTOIN SODIUM

PHENYTOIN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand nameEXTENDED PHENYTOIN SODIUM
Active ingredientPHENYTOIN SODIUM
Strength100MG EXTENDED
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2006
Marketing statusRX

More from Taro Pharmaceutical Industries

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.